Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer

por Khorrami, Mohammadhadi, Viswanathan, Vidya Sakar, Reddy, Priyanka, Braman, Nathaniel, Kunte, Siddharth, Gupta, Amit, Abraham, Jame, Montero, Alberto J., Madabhushi, Anant
Publicado 2023

Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score

por Mariotti, Veronica, Page, David B., Davydov, Oksana, Hans, Didier, Hudis, Clifford A., Patil, Sujata, Kunte, Siddharth, Girotra, Monica, Farooki, Azeez, Fornier, Monica N.
Publicado 2016

RET inhibition in novel patient-derived models of RET fusion- positive lung adenocarcinoma reveals a role for MYC upregulation

por Hayashi, Takuo, Odintsov, Igor, Smith, Roger S., Ishizawa, Kota, Liu, Allan J. W., Delasos, Lukas, Kurzatkowski, Christopher, Tai, Huichun, Gladstone, Eric, Vojnic, Morana, Kohsaka, Shinji, Suzawa, Ken, Liu, Zebing, Kunte, Siddharth, Mattar, Marissa S., Khodos, Inna, Davare, Monika A., Drilon, Alexander, Cheng, Emily, de Stanchina, Elisa, Ladanyi, Marc, Somwar, Romel
Publicado 2021

Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling

por Smith, Roger S., Odintsov, Igor, Liu, Zebing, Lui, Allan Jo-Weng, Hayashi, Takuo, Vojnic, Morana, Suehara, Yoshiyuki, Delasos, Lukas, Mattar, Marissa S., Hmeljak, Julija, Ramirez, Hillary A., Shaw, Melissa, Bui, Gabrielle, Hartono, Alifiani B., Gladstone, Eric, Kunte, Siddharth, Magnan, Heather, Khodos, Inna, De Stanchina, Elisa, La Quaglia, Michael P., Yao, Jinjuan, Laé, Marick, Lee, Sean B., Spraggon, Lee, Pratilas, Christine A., Ladanyi, Marc, Somwar, Romel
Publicado 2022

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

por Miyazaki, Isao, Odintsov, Igor, Ishida, Keiji, Lui, Allan J. W., Kato, Masanori, Suzuki, Tatsuya, Zhang, Tom, Wakayama, Kentaro, Kurth, Renate I., Cheng, Ryan, Fujita, Hidenori, Delasos, Lukas, Vojnic, Morana, Khodos, Inna, Yamada, Yukari, Ishizawa, Kota, Mattar, Marissa S., Funabashi, Kaoru, Chang, Qing, Ohkubo, Shuichi, Yano, Wakako, Terada, Ryuichiro, Giuliano, Claudio, Lu, Yue Christine, Bonifacio, Annalisa, Kunte, Siddharth, Davare, Monika A., Cheng, Emily H., de Stanchina, Elisa, Lovati, Emanuela, Iwasawa, Yoshikazu, Ladanyi, Marc, Somwar, Romel
Publicado 2023

Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

por Miyazaki, Isao, Odintsov, Igor, Ishida, Keiji, Lui, Allan J. W., Kato, Masanori, Suzuki, Tatsuya, Zhang, Tom, Wakayama, Kentaro, Kurth, Renate I., Cheng, Ryan, Fujita, Hidenori, Delasos, Lukas, Vojnic, Morana, Khodos, Inna, Yamada, Yukari, Ishizawa, Kota, Mattar, Marissa S., Funabashi, Kaoru, Chang, Qing, Ohkubo, Shuichi, Yano, Wakako, Terada, Ryuichiro, Giuliano, Claudio, Lu, Yue Christine, Bonifacio, Annalisa, Kunte, Siddharth, Davare, Monika A., Cheng, Emily H., de Stanchina, Elisa, Lovati, Emanuela, Iwasawa, Yoshikazu, Ladanyi, Marc, Somwar, Romel
Publicado 2023